Resources

Publications

05/26/2019
- Oncology
Transcriptome-based Cancer Type Prediction for Tumors of Unknown Origin
05/26/2019
- Oncology
Real-world Outcomes of Patients with Advanced Non-small Cell Lung Cancer (aNSCLC) and Autoimmune Disease (AD) Receiving Immune Checkpoint Inhibitors (ICIs)
05/26/2019
- Oncology
Real-world Characteristics and Outcomes of Patients with Advanced Non-small Cell Lung Cancer (aNSCLC) Receiving Immune Checkpoint Inhibitor
05/26/2019
- Oncology
Characteristics of Patients Receiving Immune Checkpoint Inhibitors (ICI) in ASCO’s CancerLinQ
ASCO Annual Meeting 2019
05/26/2019
- Oncology
Real-world Prevalence of Autoimmune Disease (AD) Among Patients (pts) Receiving Immune Checkpoint Inhibitors (ICI) in ASCO’s CancerLinQ Database
ASCO Annual Meeting 2019
05/26/2019
- Oncology
Overestimation of Tumor Mutational Burden (TMB) Using Algorithms Compared to Germline Subtraction
ASCO Annual Meeting 2019
05/26/2019
- Oncology
Determining Clinical Relevance of Genomic Heterogeneity in an Ethnically Diverse Cohort of Newly Diagnosed Patients with Breast Cancer
ASCO Annual Meeting 2019
05/26/2019
- Oncology
Genomic Profiling of Residual Tumor after Neoadjuvant Chemotherapy for Breast Cancer
ASCO Annual Meeting 2019
05/26/2019
- Oncology
A Phase II Single-arm Study of Nivolumab and Ipilimumab (Nivo/Ipi) in Previously Treated Classic Kaposi Sarcoma (CKS)
ASCO Annual Meeting 2019
05/26/2019
- Oncology
Design and Development of the Molecular Analysis for Therapy Choice (NCI-MATCH) Designated Laboratory Network
ASCO Annual Meeting 2019

70 71 72